Akari Takahashi Selected Research

Colonic Neoplasms (Colon Cancer)

1/2016	Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy.
4/2014	Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.
4/2013	DNA methyltransferase 1 is essential for initiation of the colon cancers.
1/2013	Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients.
2/2012	Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
6/2011	Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients.
4/2011	Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akari Takahashi Research Topics

Disease

27	Neoplasms (Cancer) 09/2023 - 06/2009
7	Colonic Neoplasms (Colon Cancer) 01/2016 - 04/2011
4	Ischemia 03/2007 - 04/2006
3	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2013
3	Infarction (Infarctions) 03/2007 - 08/2006
2	Margins of Excision 09/2023 - 10/2022
2	Sarcoma (Soft Tissue Sarcoma) 02/2020 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018 - 01/2013
2	Testicular Neoplasms (Testicular Cancer) 03/2016 - 06/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 04/2014 - 06/2011
2	Prostatic Neoplasms (Prostate Cancer) 04/2013 - 07/2012
2	Lung Neoplasms (Lung Cancer) 12/2011 - 08/2009
2	Tics (Tic) 04/2011 - 03/2010
1	Rare Diseases (Rare Disease) 09/2023
1	Disease Progression 09/2023
1	Hemorrhage 09/2023
1	Anaplastic Thyroid Carcinoma 09/2023
1	Fistula 09/2023
1	Asphyxia (Suffocation) 09/2023
1	Dehydration (Water Stress) 01/2023
1	Pancreatitis 01/2023
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2022
1	Ductal Carcinoma 04/2022
1	Breast Neoplasms (Breast Cancer) 04/2022
1	Necrosis 02/2020
1	Nausea 10/2018
1	Fatigue 10/2018
1	Headache (Headaches) 10/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2016
1	Delirium 01/2015
1	Cognitive Dysfunction 01/2015
1	Lewy Body Disease (Lewy Body Dementia) 01/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2013
1	Ovarian Epithelial Carcinoma 01/2013
1	Adenocarcinoma of Lung 01/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Clear Cell Adenocarcinoma 01/2013
1	Adenocarcinoma 01/2013
1	Carcinoma (Carcinomatosis) 01/2013

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 02/2020 - 06/2009
8	AntigensIBA 03/2016 - 06/2009
7	Proteins (Proteins, Gene)FDA Link 01/2015 - 08/2009
6	SurvivinIBA 02/2020 - 11/2009
5	Protein Subunit VaccinesIBA 10/2018 - 06/2009
3	incomplete Freund's adjuvantIBA 02/2020 - 06/2011
3	EpitopesIBA 01/2015 - 06/2009
3	Cancer VaccinesIBA 01/2013 - 04/2011
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2015 - 01/2015
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2015 - 01/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2014 - 02/2012
2	Aldehyde DehydrogenaseIBA 01/2013 - 07/2012
2	Messenger RNA (mRNA)IBA 01/2013 - 08/2009
2	Coloring Agents (Dyes)IBA 12/2011 - 04/2011
2	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 12/2011 - 04/2011
2	Inhibitor of Apoptosis ProteinsIBA 02/2011 - 11/2009
2	Erythropoietin FDA Link 03/2007 - 04/2006
2	salicylhydroxamic acid (SHAM)IBA 03/2007 - 04/2006
1	lenvatinibIBA 09/2023
1	evocalcetIBA 01/2023
1	Zoledronic Acid (Zometa)FDA Link 01/2023
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2023
1	Furosemide (Lasix)FDA LinkGeneric 01/2023
1	Capsules (Microcapsules)IBA 10/2022
1	Imatinib Mesylate (Gleevec)FDA Link 10/2022
1	Phenobarbital (Luminal)FDA Link 04/2022
1	Trastuzumab (Herceptin)FDA Link 04/2022
1	Interferon-alpha (Interferon Alfa)IBA 02/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2020
1	TegafurIBA 10/2018
1	UracilIBA 10/2018
1	Gemcitabine FDA Link 10/2018
1	sulfur tetrafluorideIBA 03/2016
1	Odorant Receptors (Odorant Receptor)IBA 01/2016
1	AntibodiesIBA 01/2015
1	Histocompatibility Antigens Class IIBA 01/2015
1	Phosphotransferases (Kinase)IBA 09/2013
1	Proline (L-Proline)FDA Link 09/2013
1	MethyltransferasesIBA 04/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2013
1	Small Interfering RNA (siRNA)IBA 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2013
1	Cysteine (L-Cysteine)FDA Link 01/2013
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2013
1	AldehydesIBA 01/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	InterferonsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013

Therapy/Procedure

17	Therapeutics 01/2023 - 08/2009
9	Immunotherapy 02/2020 - 06/2009
7	Drug Therapy (Chemotherapy) 09/2023 - 03/2010
3	Radiotherapy 03/2016 - 03/2010
2	Aftercare (After-Treatment) 01/2013 - 01/2013
2	Ligation 03/2007 - 04/2006
1	Extracorporeal Membrane Oxygenation 01/2023
1	Neoadjuvant Therapy 10/2022
1	Local Anesthesia 04/2022